BLA resubmission anticipated in second half of 2024 Closed $75 million underwritten offering in May, extending expected cash ...
Cleveland-based Abeona Therapeutics Inc. (Nasdaq: ABEO) says a recent financing round has extended its cash runway into 2026, ...
CLEVELAND — CLEVELAND — Abeona Therapeutics Inc. (ABEO) on Wednesday reported a loss of $31.6 million in its first quarter. On a per-share basis, the Cleveland-based company said it had a loss of ...
Greg Gin; Vice President, Investor Relations and Corporate Communications; Abeona Therapeutics Inc Vishwas Seshadri; President, Chief Executive Officer, Director; Abeona Therapeutics Inc Madhav ...
Closed $75 million underwritten offering in May, extending expected cash runway into 2026 CLEVELAND, May 15, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported ...
CLEVELAND (AP) — CLEVELAND (AP) — Abeona Therapeutics Inc. (ABEO) on Wednesday reported a loss of $31.6 million in its first quarter. On a per-share basis, the Cleveland-based company said it ...